ID

21499

Description

NCT00340080 / VIIV-CNA106030 A phase IV, randomised, multicentre, double-blind, study to evaluate the clinical utility of prospective genetic screening (HLA-B*5701) for susceptibility to abacavir hypersensitivity Assessment: HIV associated conditions Medicine: abacavir, Condition: Infection, Human Immunodeficiency Virus, Phase: 4, Clinical Study ID: CNA106030, Sponsor: ViiV

Keywords

  1. 4/25/17 4/25/17 -
Uploaded on

April 25, 2017

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :


No comments

In order to download data models you must be logged in. Please log in or register for free.

Genetic Screening For HLA-B*5701 in Patients with HIV HIV associated conditions NCT00340080

Genetic Screening For HLA-B*5701 HIV associated conditions NCT00340080

HIV associated conditions
Description

HIV associated conditions

Alias
UMLS CUI-1
C0276555
Subject Identifier
Description

Subject Identifier

Data type

text

Alias
UMLS CUI [1]
C2348585
Did the subject experience any HIV-associated conditions after Screening
Description

If Yes, record HIV-associated conditions experienced after Screening below using the codes on facing page.

Data type

text

Alias
UMLS CUI [1]
C0276555
HIV-Associated Conditions
Description

If Yes, record HIV-associated conditions experienced after Screening below using the codes on facing page. If code ’BOT’ (Other), provide text

Data type

text

Alias
UMLS CUI [1]
C0276555
HIV-Associated Conditions Other text
Description

If code ’BOT’ (Other), provide text

Data type

text

Alias
UMLS CUI [1]
C0276555
Start Date
Description

Start Date

Data type

date

Alias
UMLS CUI [1,1]
C0808070
UMLS CUI [1,2]
C0276555
Has the subject previously had this condition?
Description

previously had this condition

Data type

text

Alias
UMLS CUI [1]
C0276555

Similar models

Genetic Screening For HLA-B*5701 HIV associated conditions NCT00340080

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
HIV associated conditions
C0276555 (UMLS CUI-1)
Subject Identifier
Item
Subject Identifier
text
C2348585 (UMLS CUI [1])
Item
Did the subject experience any HIV-associated conditions after Screening
text
C0276555 (UMLS CUI [1])
Code List
Did the subject experience any HIV-associated conditions after Screening
CL Item
Yes (Y)
CL Item
No (N)
Item
HIV-Associated Conditions
text
C0276555 (UMLS CUI [1])
Code List
HIV-Associated Conditions
CL Item
Bacillary angiomatosis (B1)
CL Item
Candidiasis, oropharyngeal (thrush) (B2)
CL Item
Candidiasis, vulvovaginal; persistent, frequent or poorly responsive to therapy (B3)
CL Item
Cervical dysplasia (moderate or severe)/cervical carcinoma in situ (B4)
CL Item
Constitutional symptoms, such as fever (38.5 C) or diarrhea lasting greater than 1 month (B26)
CL Item
Hairy leukoplakia, oral (B7)
CL Item
Herpes zoster (shingles), involving at least two distinct episodes or more than one dermatome (B8)
CL Item
Idiopathic thrombocytopenic purpura  (B9)
CL Item
Listeriosis (B10)
CL Item
Pelvic inflammatory disease, particularly if complicated by tubo-ovarian abscess (B11)
CL Item
Peripheral neuropathy  (B12)
CL Item
Other, specify in table. (BOT)
CL Item
Candidiasis of bronchi, trachea, or lungs (C1)
CL Item
Candidiasis, esophageal (C2)
CL Item
Cervical cancer, invasive (C3)
CL Item
Coccidioidomycosis, disseminated or extrapulmonary (C4)
CL Item
Cryptococcosis, extrapulmonary (C5)
CL Item
Cytomegalovirus disease (other than liver, spleen, or nodes) (C7)
CL Item
Cytomegalovirus retinitis (with loss of vision) (C8)
CL Item
Encephalopathy, HIV-related (C9)
CL Item
Herpes simplex: chronic ulcer(s) (greater than 1 month’s duration); or bronchitis, pneumonitis, or esophagitis (C10)
CL Item
Histoplasmosis, disseminated or extrapulmonary (C11)
CL Item
Isosporiasis, chronic intestinal (greater than 1 month’s duration) (C12)
CL Item
Kaposi’s sarcoma (C29)
CL Item
Lymphoma, Burkitt’s (or equivalent term) (C15)
CL Item
Lymphoma, immunoblastic (or equivalent term)  (C16)
CL Item
Lymphoma, primary, of brain (C17)
CL Item
Mycobacterium avium complex or M. kansasii, disseminated or extrapulmonary (C18)
CL Item
Mycobacterium tuberculosis, any site (pulmonary or extrapulmonary) (C19)
CL Item
Mycobacterium, other species or unidentified species, disseminated or extrapulmonary (C20)
CL Item
Pneumocystis carinii pneumonia (C21)
CL Item
Pneumonia, recurrent (C22)
CL Item
Progressive multifocal leukoencephalopathy  (C23)
CL Item
Salmonella septicemia, recurrent  (C24)
CL Item
Toxoplasmosis of brain (C25)
CL Item
Wasting syndrome due to HIV (C26)
CL Item
Cryptosporidiosis, chronic intestinal (greater than 1 month’s duration) (C31)
HIV-Associated Conditions
Item
HIV-Associated Conditions Other text
text
C0276555 (UMLS CUI [1])
Start Date
Item
Start Date
date
C0808070 (UMLS CUI [1,1])
C0276555 (UMLS CUI [1,2])
Item
Has the subject previously had this condition?
text
C0276555 (UMLS CUI [1])
Code List
Has the subject previously had this condition?
CL Item
Yes (Y)
CL Item
No (N)

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial